61564-89-4 Usage
General Description
5-BROMO-2-PROPOXYBENZALDEHYDE is a chemical compound with the molecular formula C10H11BrO2. It is a pale yellow solid that is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It is a versatile building block in organic chemistry and is often used as a reagent for the preparation of various functionalized benzaldehydes. 5-BROMO-2-PROPOXYBENZALDEHYDE may also have the potential to be used in the development of new drugs and pharmaceutical products due to its structural properties and reactivity. Additionally, 5-BROMO-2-PROPOXYBENZALDEHYDE may also be used in chemical research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 61564-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,5,6 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 61564-89:
(7*6)+(6*1)+(5*5)+(4*6)+(3*4)+(2*8)+(1*9)=134
134 % 10 = 4
So 61564-89-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H11BrO2/c1-2-5-13-10-4-3-9(11)6-8(10)7-12/h3-4,6-7H,2,5H2,1H3
61564-89-4Relevant articles and documents
COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF
-
Page/Page column 29; 32; 39, (2021/02/12)
Scaffold compounds are used to design small molecule compounds and structure- activity relationship studies identify inhibitors of inflammation· Methods include pharmaceutical compositions of the small molecule compounds to inhibit, prevent and treat dise
Discovery of Second-Generation NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
Jiang, Yuqi,He, Liu,Green, Jakob,Blevins, Hallie,Guo, Chunqing,Patel, Sulay Harsiddhbhai,Halquist, Matthew S.,McRae, MaryPeace,Venitz, Jürgen,Wang, Xiang-Yang,Zhang, Shijun
, p. 9718 - 9731 (2019/11/13)
NLRP3 inflammasomes have recently emerged as an attractive drug target for neurodegenerative disorders. In our continuing studies, a new chemical scaffold was designed as selective inhibitors of NLRP3 inflammasomes. Initial characterization of the lead HL
